Abstract
Triple negative breast cancer (TNBC) has a poor prognosis. TNBC does not respond to targeted therapy, unlike HER2+ and hormone receptor-positive Breast Cancer, and chemotherapy remains the major treatment option. As a result, there is an unmet demand for effective TNBC therapy. RTKs (Receptor Tyrosine Kinases) are a type of receptor that plays a key role in cancer growth. The RTK family includes the insulin-like growth factor receptor (IGFR). The insulin-like growth factor 1 (IGF-I) axis regulates MAPK, PI3K/AKt, and JAK/STAT signalling pathways, all of which are important in the progression of Breast Cancer. The function of such pathways in the regulation of metastasis, angiogenesis, and tumour stem cells is well known. The main goal of this chapter was to discuss the specific role of tyrosine kinase receptors and their involvement in TNBC-promoting signalling pathways.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
